Perivillous fibrin deposition is an abnormal accumulation of fibrin (a protein involved in blood clotting) around the placental villi in the maternal-fetal interface. It is associated with conditions like placental abruption and intrauterine growth restriction, which can lead to pregnancy complications. Excessive fibrin deposition can impair blood flow in the placenta and compromise fetal development.
Fibrinogen is converted into fibrin during the blood clotting process. This conversion is catalyzed by the enzyme thrombin, which cleaves specific peptide bonds in fibrinogen to form fibrin monomers. These monomers then polymerize to form a mesh-like structure that helps to stabilize the blood clot.
deposition
Deposition. Erosion is the process of wearing away or carrying away materials, while deposition is the process of dropping or depositing those materials in a new location.
Low deposition rate in sputter deposition can be attributed to factors such as low sputter yield of the target material, insufficient power or pressure to sustain sputtering, inefficient target utilization, or poor target-substrate geometry leading to inefficient material transfer. Increasing any of these factors can help improve the deposition rate in sputter deposition.
Weathering: disintegration, decomposition, deterioration Erosion: abrasion, corrosion, scouring Deposition: accumulation, sedimentation, deposit
This phenomenon is called coagulation: agglomeration of blood platelets and deposition of fibrin.
Fibrin sealants are also called fibrin glues
Alan PB Dackiw has written: 'Induction and modulation of monocyte/macrophage tissue factor/fibrin deposition and TNF secretion in the microenvironment of inflammation'
fibrinogen to fibrin.
Fibrin is found in the Circulatory System.
Fibrin strands form when fibrinogen is converted into fibrin by the enzyme thrombin during the blood clotting process. Thrombin acts on fibrinogen to create fibrin monomers, which then polymerize into a network of fibrin strands that help to trap platelets and form a stable blood clot.
Thrombin cleaves fibrinogen to form fibrin.
Fibrin is a specific type of protein that is involved in blood clotting.
fibrin molecules converting them into an insoluble meshwork - the clot
Fibrinous. Fibrin can also be referred to as blood Factor LA.
Streptokinase specifically targets fibrin due to its ability to bind to plasminogen, converting it into plasmin, which then digests fibrin in blood clots. This action is selective because fibrin is a component of blood clots, whereas healthy tissues do not contain significant amounts of fibrin. Additionally, the enzymatic activity of plasmin is primarily aimed at fibrin and does not have the same affinity for other tissue components. Thus, while there is a risk of some collateral damage, the primary action of streptokinase is to dissolve fibrin in clots.
A blood clot is a semisolid gelatinous mass of coagulated consisting of red blood cells, white blood cells, and platelets enclosed in a fibrin network. A great variety of structural proteins are present in a blood clot, for instance haemoglobin in red blood cells, antibodies in white blood cells, and fibrin in the platelets.